| UniProt ID | ACSF2_HUMAN | |
|---|---|---|
| UniProt AC | Q96CM8 | |
| Protein Name | Acyl-CoA synthetase family member 2, mitochondrial | |
| Gene Name | ACSF2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 615 | |
| Subcellular Localization | Mitochondrion . | |
| Protein Description | Acyl-CoA synthases catalyze the initial reaction in fatty acid metabolism, by forming a thioester with CoA. Has some preference toward medium-chain substrates. Plays a role in adipocyte differentiation.. | |
| Protein Sequence | MAVYVGMLRLGRLCAGSSGVLGARAALSRSWQEARLQGVRFLSSREVDRMVSTPIGGLSYVQGCTKKHLNSKTVGQCLETTAQRVPEREALVVLHEDVRLTFAQLKEEVDKAASGLLSIGLCKGDRLGMWGPNSYAWVLMQLATAQAGIILVSVNPAYQAMELEYVLKKVGCKALVFPKQFKTQQYYNVLKQICPEVENAQPGALKSQRLPDLTTVISVDAPLPGTLLLDEVVAAGSTRQHLDQLQYNQQFLSCHDPINIQFTSGTTGSPKGATLSHYNIVNNSNILGERLKLHEKTPEQLRMILPNPLYHCLGSVAGTMMCLMYGATLILASPIFNGKKALEAISRERGTFLYGTPTMFVDILNQPDFSSYDISTMCGGVIAGSPAPPELIRAIINKINMKDLVVAYGTTENSPVTFAHFPEDTVEQKAESVGRIMPHTEARIMNMEAGTLAKLNTPGELCIRGYCVMLGYWGEPQKTEEAVDQDKWYWTGDVATMNEQGFCKIVGRSKDMIIRGGENIYPAELEDFFHTHPKVQEVQVVGVKDDRMGEEICACIRLKDGEETTVEEIKAFCKGKISHFKIPKYIVFVTNYPLTISGKIQKFKLREQMERHLNL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 17 | Phosphorylation | LGRLCAGSSGVLGAR HHHHCCCCCCHHHHH | 12.85 | 68717059 | |
| 18 | Phosphorylation | GRLCAGSSGVLGARA HHHCCCCCCHHHHHH | 31.81 | 68717065 | |
| 52 | Phosphorylation | REVDRMVSTPIGGLS HHHHHHCCCCCCCHH | 21.08 | 22964224 | |
| 53 | Phosphorylation | EVDRMVSTPIGGLSY HHHHHCCCCCCCHHH | 13.91 | 100646223 | |
| 59 | Phosphorylation | STPIGGLSYVQGCTK CCCCCCHHHHCCCCH | 26.91 | 100646215 | |
| 60 | Phosphorylation | TPIGGLSYVQGCTKK CCCCCHHHHCCCCHH | 11.22 | 100646231 | |
| 65 | Phosphorylation | LSYVQGCTKKHLNSK HHHHCCCCHHHCCCC | 50.37 | 46158031 | |
| 66 | Malonylation | SYVQGCTKKHLNSKT HHHCCCCHHHCCCCC | 42.12 | 26320211 | |
| 66 | Acetylation | SYVQGCTKKHLNSKT HHHCCCCHHHCCCCC | 42.12 | 25953088 | |
| 71 | Phosphorylation | CTKKHLNSKTVGQCL CCHHHCCCCCHHHHH | 35.74 | 50563217 | |
| 72 | Malonylation | TKKHLNSKTVGQCLE CHHHCCCCCHHHHHH | 46.27 | 26320211 | |
| 106 | 2-Hydroxyisobutyrylation | RLTFAQLKEEVDKAA HHHHHHHHHHHHHHH | 39.48 | - | |
| 136 | Acetylation | MWGPNSYAWVLMQLA CCCCCHHHHHHHHHH | 6.96 | 19608861 | |
| 179 | Succinylation | CKALVFPKQFKTQQY CCEEECCHHHCHHHH | 57.83 | 27452117 | |
| 179 | Acetylation | CKALVFPKQFKTQQY CCEEECCHHHCHHHH | 57.83 | 27178108 | |
| 182 | Succinylation | LVFPKQFKTQQYYNV EECCHHHCHHHHHHH | 42.82 | - | |
| 182 | Succinylation | LVFPKQFKTQQYYNV EECCHHHCHHHHHHH | 42.82 | 27452117 | |
| 182 | Acetylation | LVFPKQFKTQQYYNV EECCHHHCHHHHHHH | 42.82 | 25953088 | |
| 182 | Malonylation | LVFPKQFKTQQYYNV EECCHHHCHHHHHHH | 42.82 | 26320211 | |
| 274 | Phosphorylation | TGSPKGATLSHYNIV CCCCCCCEEEEEEEC | 37.15 | 22468782 | |
| 276 | Phosphorylation | SPKGATLSHYNIVNN CCCCCEEEEEEECCC | 21.41 | 22468782 | |
| 278 | Phosphorylation | KGATLSHYNIVNNSN CCCEEEEEEECCCCC | 11.83 | 22468782 | |
| 283 | Acetylation | SHYNIVNNSNILGER EEEEECCCCCCCCHH | 26.07 | 19608861 | |
| 296 | Acetylation | ERLKLHEKTPEQLRM HHHHHCCCCHHHHHH | 59.64 | 19608861 | |
| 321 | Acetylation | GSVAGTMMCLMYGAT HHHHHHHHHHHHHHH | 1.27 | 19608861 | |
| 340 | Succinylation | SPIFNGKKALEAISR CHHHCCHHHHHHHHH | 60.65 | 27452117 | |
| 340 | Malonylation | SPIFNGKKALEAISR CHHHCCHHHHHHHHH | 60.65 | 26320211 | |
| 340 | Acetylation | SPIFNGKKALEAISR CHHHCCHHHHHHHHH | 60.65 | - | |
| 398 | Acetylation | LIRAIINKINMKDLV HHHHHHHHCCHHHEE | 25.67 | - | |
| 417 | O-linked_Glycosylation | TTENSPVTFAHFPED CCCCCCCEEECCCCC | 20.63 | 29351928 | |
| 466 | Phosphorylation | GELCIRGYCVMLGYW CCEEEEEEEEECCCC | 3.36 | 24719451 | |
| 472 | Phosphorylation | GYCVMLGYWGEPQKT EEEEECCCCCCCCCC | 13.28 | 25147952 | |
| 478 | Succinylation | GYWGEPQKTEEAVDQ CCCCCCCCCCCCHHC | 69.49 | - | |
| 478 | Succinylation | GYWGEPQKTEEAVDQ CCCCCCCCCCCCHHC | 69.49 | - | |
| 510 | Malonylation | CKIVGRSKDMIIRGG EEEEECCCCEEEECC | 50.37 | 26320211 | |
| 510 | Acetylation | CKIVGRSKDMIIRGG EEEEECCCCEEEECC | 50.37 | - | |
| 531 | Phosphorylation | ELEDFFHTHPKVQEV HHHHHHCCCCCEEEE | 34.42 | 25159151 | |
| 544 | Succinylation | EVQVVGVKDDRMGEE EEEEEEECCCCCCCE | 48.24 | - | |
| 544 | Succinylation | EVQVVGVKDDRMGEE EEEEEEECCCCCCCE | 48.24 | - | |
| 544 | Acetylation | EVQVVGVKDDRMGEE EEEEEEECCCCCCCE | 48.24 | - | |
| 564 | Phosphorylation | RLKDGEETTVEEIKA ECCCCCCCCHHHHHH | 31.66 | 110756093 | |
| 570 | Acetylation | ETTVEEIKAFCKGKI CCCHHHHHHHHCCCC | 38.39 | - | |
| 570 | Succinylation | ETTVEEIKAFCKGKI CCCHHHHHHHHCCCC | 38.39 | - | |
| 570 | Succinylation | ETTVEEIKAFCKGKI CCCHHHHHHHHCCCC | 38.39 | - | |
| 585 | Phosphorylation | SHFKIPKYIVFVTNY CCCCCCCEEEEEECC | 9.28 | 25690035 | |
| 592 | Phosphorylation | YIVFVTNYPLTISGK EEEEEECCCEEECCH | 7.11 | 18491316 | |
| 595 | Phosphorylation | FVTNYPLTISGKIQK EEECCCEEECCHHHH | 14.48 | 50563209 | |
| 597 | Phosphorylation | TNYPLTISGKIQKFK ECCCEEECCHHHHHH | 28.88 | 18491316 | |
| 599 | Succinylation | YPLTISGKIQKFKLR CCEEECCHHHHHHHH | 34.86 | - | |
| 599 | Succinylation | YPLTISGKIQKFKLR CCEEECCHHHHHHHH | 34.86 | - | |
| 609 | Ubiquitination | KFKLREQMERHLNL- HHHHHHHHHHHHCC- | 4.13 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ACSF2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ACSF2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ACSF2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CKLF5_HUMAN | CMTM5 | physical | 25416956 | |
| GBB2_HUMAN | GNB2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-296, AND MASS SPECTROMETRY. | |